Global TCR-Based Antibody Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them.
LPI (LP Information)' newest research report, the “TCR-Based Antibody Industry Forecast” looks at past sales and reviews total world TCR-Based Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected TCR-Based Antibody sales for 2023 through 2029. With TCR-Based Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TCR-Based Antibody industry.
This Insight Report provides a comprehensive analysis of the global TCR-Based Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TCR-Based Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global TCR-Based Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TCR-Based Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TCR-Based Antibody.
The global TCR-Based Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for TCR-Based Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for TCR-Based Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for TCR-Based Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key TCR-Based Antibody players cover Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of TCR-Based Antibody market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global TCR-Based Antibody market?
What factors are driving TCR-Based Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TCR-Based Antibody market opportunities vary by end market size?
How does TCR-Based Antibody break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them.
LPI (LP Information)' newest research report, the “TCR-Based Antibody Industry Forecast” looks at past sales and reviews total world TCR-Based Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected TCR-Based Antibody sales for 2023 through 2029. With TCR-Based Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TCR-Based Antibody industry.
This Insight Report provides a comprehensive analysis of the global TCR-Based Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TCR-Based Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global TCR-Based Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TCR-Based Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TCR-Based Antibody.
The global TCR-Based Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for TCR-Based Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for TCR-Based Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for TCR-Based Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key TCR-Based Antibody players cover Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics, Lion TCR, Kite Pharma, Takara Bio, Ziopharm Oncology and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of TCR-Based Antibody market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- NY-ESO-1
- p53
- WT-1
- EBv
- Others
- Hospitals
- Specialized Clinics
- Pharma and Biotech Research Laboratories.
- Gene Therapy Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Adaptimmune Therapeutics
- Celgene
- Immunocore
- Kuur Therapeutics
- Lion TCR
- Kite Pharma
- Takara Bio
- Ziopharm Oncology
- GlaxoSmithKline
- Merck
- Juno Theraprutics
What is the 10-year outlook for the global TCR-Based Antibody market?
What factors are driving TCR-Based Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TCR-Based Antibody market opportunities vary by end market size?
How does TCR-Based Antibody break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TCR-Based Antibody Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for TCR-Based Antibody by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for TCR-Based Antibody by Country/Region, 2018, 2022 & 2029
2.2 TCR-Based Antibody Segment by Type
2.2.1 NY-ESO-1
2.2.2 p53
2.2.3 WT-1
2.2.4 EBv
2.2.5 Others
2.3 TCR-Based Antibody Sales by Type
2.3.1 Global TCR-Based Antibody Sales Market Share by Type (2018-2023)
2.3.2 Global TCR-Based Antibody Revenue and Market Share by Type (2018-2023)
2.3.3 Global TCR-Based Antibody Sale Price by Type (2018-2023)
2.4 TCR-Based Antibody Segment by Application
2.4.1 Hospitals
2.4.2 Specialized Clinics
2.4.3 Pharma and Biotech Research Laboratories.
2.4.4 Gene Therapy Centers
2.4.5 Others
2.5 TCR-Based Antibody Sales by Application
2.5.1 Global TCR-Based Antibody Sale Market Share by Application (2018-2023)
2.5.2 Global TCR-Based Antibody Revenue and Market Share by Application (2018-2023)
2.5.3 Global TCR-Based Antibody Sale Price by Application (2018-2023)
3 GLOBAL TCR-BASED ANTIBODY BY COMPANY
3.1 Global TCR-Based Antibody Breakdown Data by Company
3.1.1 Global TCR-Based Antibody Annual Sales by Company (2018-2023)
3.1.2 Global TCR-Based Antibody Sales Market Share by Company (2018-2023)
3.2 Global TCR-Based Antibody Annual Revenue by Company (2018-2023)
3.2.1 Global TCR-Based Antibody Revenue by Company (2018-2023)
3.2.2 Global TCR-Based Antibody Revenue Market Share by Company (2018-2023)
3.3 Global TCR-Based Antibody Sale Price by Company
3.4 Key Manufacturers TCR-Based Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TCR-Based Antibody Product Location Distribution
3.4.2 Players TCR-Based Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TCR-BASED ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic TCR-Based Antibody Market Size by Geographic Region (2018-2023)
4.1.1 Global TCR-Based Antibody Annual Sales by Geographic Region (2018-2023)
4.1.2 Global TCR-Based Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic TCR-Based Antibody Market Size by Country/Region (2018-2023)
4.2.1 Global TCR-Based Antibody Annual Sales by Country/Region (2018-2023)
4.2.2 Global TCR-Based Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas TCR-Based Antibody Sales Growth
4.4 APAC TCR-Based Antibody Sales Growth
4.5 Europe TCR-Based Antibody Sales Growth
4.6 Middle East & Africa TCR-Based Antibody Sales Growth
5 AMERICAS
5.1 Americas TCR-Based Antibody Sales by Country
5.1.1 Americas TCR-Based Antibody Sales by Country (2018-2023)
5.1.2 Americas TCR-Based Antibody Revenue by Country (2018-2023)
5.2 Americas TCR-Based Antibody Sales by Type
5.3 Americas TCR-Based Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TCR-Based Antibody Sales by Region
6.1.1 APAC TCR-Based Antibody Sales by Region (2018-2023)
6.1.2 APAC TCR-Based Antibody Revenue by Region (2018-2023)
6.2 APAC TCR-Based Antibody Sales by Type
6.3 APAC TCR-Based Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TCR-Based Antibody by Country
7.1.1 Europe TCR-Based Antibody Sales by Country (2018-2023)
7.1.2 Europe TCR-Based Antibody Revenue by Country (2018-2023)
7.2 Europe TCR-Based Antibody Sales by Type
7.3 Europe TCR-Based Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TCR-Based Antibody by Country
8.1.1 Middle East & Africa TCR-Based Antibody Sales by Country (2018-2023)
8.1.2 Middle East & Africa TCR-Based Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa TCR-Based Antibody Sales by Type
8.3 Middle East & Africa TCR-Based Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TCR-Based Antibody
10.3 Manufacturing Process Analysis of TCR-Based Antibody
10.4 Industry Chain Structure of TCR-Based Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TCR-Based Antibody Distributors
11.3 TCR-Based Antibody Customer
12 WORLD FORECAST REVIEW FOR TCR-BASED ANTIBODY BY GEOGRAPHIC REGION
12.1 Global TCR-Based Antibody Market Size Forecast by Region
12.1.1 Global TCR-Based Antibody Forecast by Region (2024-2029)
12.1.2 Global TCR-Based Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TCR-Based Antibody Forecast by Type
12.7 Global TCR-Based Antibody Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Adaptimmune Therapeutics
13.1.1 Adaptimmune Therapeutics Company Information
13.1.2 Adaptimmune Therapeutics TCR-Based Antibody Product Portfolios and Specifications
13.1.3 Adaptimmune Therapeutics TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Adaptimmune Therapeutics Main Business Overview
13.1.5 Adaptimmune Therapeutics Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene TCR-Based Antibody Product Portfolios and Specifications
13.2.3 Celgene TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Immunocore
13.3.1 Immunocore Company Information
13.3.2 Immunocore TCR-Based Antibody Product Portfolios and Specifications
13.3.3 Immunocore TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Immunocore Main Business Overview
13.3.5 Immunocore Latest Developments
13.4 Kuur Therapeutics
13.4.1 Kuur Therapeutics Company Information
13.4.2 Kuur Therapeutics TCR-Based Antibody Product Portfolios and Specifications
13.4.3 Kuur Therapeutics TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kuur Therapeutics Main Business Overview
13.4.5 Kuur Therapeutics Latest Developments
13.5 Lion TCR
13.5.1 Lion TCR Company Information
13.5.2 Lion TCR TCR-Based Antibody Product Portfolios and Specifications
13.5.3 Lion TCR TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lion TCR Main Business Overview
13.5.5 Lion TCR Latest Developments
13.6 Kite Pharma
13.6.1 Kite Pharma Company Information
13.6.2 Kite Pharma TCR-Based Antibody Product Portfolios and Specifications
13.6.3 Kite Pharma TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kite Pharma Main Business Overview
13.6.5 Kite Pharma Latest Developments
13.7 Takara Bio
13.7.1 Takara Bio Company Information
13.7.2 Takara Bio TCR-Based Antibody Product Portfolios and Specifications
13.7.3 Takara Bio TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takara Bio Main Business Overview
13.7.5 Takara Bio Latest Developments
13.8 Ziopharm Oncology
13.8.1 Ziopharm Oncology Company Information
13.8.2 Ziopharm Oncology TCR-Based Antibody Product Portfolios and Specifications
13.8.3 Ziopharm Oncology TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ziopharm Oncology Main Business Overview
13.8.5 Ziopharm Oncology Latest Developments
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Information
13.9.2 GlaxoSmithKline TCR-Based Antibody Product Portfolios and Specifications
13.9.3 GlaxoSmithKline TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GlaxoSmithKline Main Business Overview
13.9.5 GlaxoSmithKline Latest Developments
13.10 Merck
13.10.1 Merck Company Information
13.10.2 Merck TCR-Based Antibody Product Portfolios and Specifications
13.10.3 Merck TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck Main Business Overview
13.10.5 Merck Latest Developments
13.11 Juno Theraprutics
13.11.1 Juno Theraprutics Company Information
13.11.2 Juno Theraprutics TCR-Based Antibody Product Portfolios and Specifications
13.11.3 Juno Theraprutics TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Juno Theraprutics Main Business Overview
13.11.5 Juno Theraprutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TCR-Based Antibody Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for TCR-Based Antibody by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for TCR-Based Antibody by Country/Region, 2018, 2022 & 2029
2.2 TCR-Based Antibody Segment by Type
2.2.1 NY-ESO-1
2.2.2 p53
2.2.3 WT-1
2.2.4 EBv
2.2.5 Others
2.3 TCR-Based Antibody Sales by Type
2.3.1 Global TCR-Based Antibody Sales Market Share by Type (2018-2023)
2.3.2 Global TCR-Based Antibody Revenue and Market Share by Type (2018-2023)
2.3.3 Global TCR-Based Antibody Sale Price by Type (2018-2023)
2.4 TCR-Based Antibody Segment by Application
2.4.1 Hospitals
2.4.2 Specialized Clinics
2.4.3 Pharma and Biotech Research Laboratories.
2.4.4 Gene Therapy Centers
2.4.5 Others
2.5 TCR-Based Antibody Sales by Application
2.5.1 Global TCR-Based Antibody Sale Market Share by Application (2018-2023)
2.5.2 Global TCR-Based Antibody Revenue and Market Share by Application (2018-2023)
2.5.3 Global TCR-Based Antibody Sale Price by Application (2018-2023)
3 GLOBAL TCR-BASED ANTIBODY BY COMPANY
3.1 Global TCR-Based Antibody Breakdown Data by Company
3.1.1 Global TCR-Based Antibody Annual Sales by Company (2018-2023)
3.1.2 Global TCR-Based Antibody Sales Market Share by Company (2018-2023)
3.2 Global TCR-Based Antibody Annual Revenue by Company (2018-2023)
3.2.1 Global TCR-Based Antibody Revenue by Company (2018-2023)
3.2.2 Global TCR-Based Antibody Revenue Market Share by Company (2018-2023)
3.3 Global TCR-Based Antibody Sale Price by Company
3.4 Key Manufacturers TCR-Based Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TCR-Based Antibody Product Location Distribution
3.4.2 Players TCR-Based Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TCR-BASED ANTIBODY BY GEOGRAPHIC REGION
4.1 World Historic TCR-Based Antibody Market Size by Geographic Region (2018-2023)
4.1.1 Global TCR-Based Antibody Annual Sales by Geographic Region (2018-2023)
4.1.2 Global TCR-Based Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic TCR-Based Antibody Market Size by Country/Region (2018-2023)
4.2.1 Global TCR-Based Antibody Annual Sales by Country/Region (2018-2023)
4.2.2 Global TCR-Based Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas TCR-Based Antibody Sales Growth
4.4 APAC TCR-Based Antibody Sales Growth
4.5 Europe TCR-Based Antibody Sales Growth
4.6 Middle East & Africa TCR-Based Antibody Sales Growth
5 AMERICAS
5.1 Americas TCR-Based Antibody Sales by Country
5.1.1 Americas TCR-Based Antibody Sales by Country (2018-2023)
5.1.2 Americas TCR-Based Antibody Revenue by Country (2018-2023)
5.2 Americas TCR-Based Antibody Sales by Type
5.3 Americas TCR-Based Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TCR-Based Antibody Sales by Region
6.1.1 APAC TCR-Based Antibody Sales by Region (2018-2023)
6.1.2 APAC TCR-Based Antibody Revenue by Region (2018-2023)
6.2 APAC TCR-Based Antibody Sales by Type
6.3 APAC TCR-Based Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe TCR-Based Antibody by Country
7.1.1 Europe TCR-Based Antibody Sales by Country (2018-2023)
7.1.2 Europe TCR-Based Antibody Revenue by Country (2018-2023)
7.2 Europe TCR-Based Antibody Sales by Type
7.3 Europe TCR-Based Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TCR-Based Antibody by Country
8.1.1 Middle East & Africa TCR-Based Antibody Sales by Country (2018-2023)
8.1.2 Middle East & Africa TCR-Based Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa TCR-Based Antibody Sales by Type
8.3 Middle East & Africa TCR-Based Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TCR-Based Antibody
10.3 Manufacturing Process Analysis of TCR-Based Antibody
10.4 Industry Chain Structure of TCR-Based Antibody
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TCR-Based Antibody Distributors
11.3 TCR-Based Antibody Customer
12 WORLD FORECAST REVIEW FOR TCR-BASED ANTIBODY BY GEOGRAPHIC REGION
12.1 Global TCR-Based Antibody Market Size Forecast by Region
12.1.1 Global TCR-Based Antibody Forecast by Region (2024-2029)
12.1.2 Global TCR-Based Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TCR-Based Antibody Forecast by Type
12.7 Global TCR-Based Antibody Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Adaptimmune Therapeutics
13.1.1 Adaptimmune Therapeutics Company Information
13.1.2 Adaptimmune Therapeutics TCR-Based Antibody Product Portfolios and Specifications
13.1.3 Adaptimmune Therapeutics TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Adaptimmune Therapeutics Main Business Overview
13.1.5 Adaptimmune Therapeutics Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene TCR-Based Antibody Product Portfolios and Specifications
13.2.3 Celgene TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Immunocore
13.3.1 Immunocore Company Information
13.3.2 Immunocore TCR-Based Antibody Product Portfolios and Specifications
13.3.3 Immunocore TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Immunocore Main Business Overview
13.3.5 Immunocore Latest Developments
13.4 Kuur Therapeutics
13.4.1 Kuur Therapeutics Company Information
13.4.2 Kuur Therapeutics TCR-Based Antibody Product Portfolios and Specifications
13.4.3 Kuur Therapeutics TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kuur Therapeutics Main Business Overview
13.4.5 Kuur Therapeutics Latest Developments
13.5 Lion TCR
13.5.1 Lion TCR Company Information
13.5.2 Lion TCR TCR-Based Antibody Product Portfolios and Specifications
13.5.3 Lion TCR TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lion TCR Main Business Overview
13.5.5 Lion TCR Latest Developments
13.6 Kite Pharma
13.6.1 Kite Pharma Company Information
13.6.2 Kite Pharma TCR-Based Antibody Product Portfolios and Specifications
13.6.3 Kite Pharma TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Kite Pharma Main Business Overview
13.6.5 Kite Pharma Latest Developments
13.7 Takara Bio
13.7.1 Takara Bio Company Information
13.7.2 Takara Bio TCR-Based Antibody Product Portfolios and Specifications
13.7.3 Takara Bio TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Takara Bio Main Business Overview
13.7.5 Takara Bio Latest Developments
13.8 Ziopharm Oncology
13.8.1 Ziopharm Oncology Company Information
13.8.2 Ziopharm Oncology TCR-Based Antibody Product Portfolios and Specifications
13.8.3 Ziopharm Oncology TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ziopharm Oncology Main Business Overview
13.8.5 Ziopharm Oncology Latest Developments
13.9 GlaxoSmithKline
13.9.1 GlaxoSmithKline Company Information
13.9.2 GlaxoSmithKline TCR-Based Antibody Product Portfolios and Specifications
13.9.3 GlaxoSmithKline TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GlaxoSmithKline Main Business Overview
13.9.5 GlaxoSmithKline Latest Developments
13.10 Merck
13.10.1 Merck Company Information
13.10.2 Merck TCR-Based Antibody Product Portfolios and Specifications
13.10.3 Merck TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck Main Business Overview
13.10.5 Merck Latest Developments
13.11 Juno Theraprutics
13.11.1 Juno Theraprutics Company Information
13.11.2 Juno Theraprutics TCR-Based Antibody Product Portfolios and Specifications
13.11.3 Juno Theraprutics TCR-Based Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Juno Theraprutics Main Business Overview
13.11.5 Juno Theraprutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. TCR-Based Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. TCR-Based Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of NY-ESO-1
Table 4. Major Players of p53
Table 5. Major Players of WT-1
Table 6. Major Players of EBv
Table 7. Major Players of Others
Table 8. Global TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 9. Global TCR-Based Antibody Sales Market Share by Type (2018-2023)
Table 10. Global TCR-Based Antibody Revenue by Type (2018-2023) & ($ million)
Table 11. Global TCR-Based Antibody Revenue Market Share by Type (2018-2023)
Table 12. Global TCR-Based Antibody Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 14. Global TCR-Based Antibody Sales Market Share by Application (2018-2023)
Table 15. Global TCR-Based Antibody Revenue by Application (2018-2023)
Table 16. Global TCR-Based Antibody Revenue Market Share by Application (2018-2023)
Table 17. Global TCR-Based Antibody Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global TCR-Based Antibody Sales by Company (2018-2023) & (K Units)
Table 19. Global TCR-Based Antibody Sales Market Share by Company (2018-2023)
Table 20. Global TCR-Based Antibody Revenue by Company (2018-2023) ($ Millions)
Table 21. Global TCR-Based Antibody Revenue Market Share by Company (2018-2023)
Table 22. Global TCR-Based Antibody Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers TCR-Based Antibody Producing Area Distribution and Sales Area
Table 24. Players TCR-Based Antibody Products Offered
Table 25. TCR-Based Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global TCR-Based Antibody Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global TCR-Based Antibody Sales Market Share Geographic Region (2018-2023)
Table 30. Global TCR-Based Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global TCR-Based Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global TCR-Based Antibody Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global TCR-Based Antibody Sales Market Share by Country/Region (2018-2023)
Table 34. Global TCR-Based Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global TCR-Based Antibody Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas TCR-Based Antibody Sales by Country (2018-2023) & (K Units)
Table 37. Americas TCR-Based Antibody Sales Market Share by Country (2018-2023)
Table 38. Americas TCR-Based Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas TCR-Based Antibody Revenue Market Share by Country (2018-2023)
Table 40. Americas TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 41. Americas TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 42. APAC TCR-Based Antibody Sales by Region (2018-2023) & (K Units)
Table 43. APAC TCR-Based Antibody Sales Market Share by Region (2018-2023)
Table 44. APAC TCR-Based Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC TCR-Based Antibody Revenue Market Share by Region (2018-2023)
Table 46. APAC TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 47. APAC TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 48. Europe TCR-Based Antibody Sales by Country (2018-2023) & (K Units)
Table 49. Europe TCR-Based Antibody Sales Market Share by Country (2018-2023)
Table 50. Europe TCR-Based Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe TCR-Based Antibody Revenue Market Share by Country (2018-2023)
Table 52. Europe TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 53. Europe TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa TCR-Based Antibody Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa TCR-Based Antibody Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa TCR-Based Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa TCR-Based Antibody Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of TCR-Based Antibody
Table 61. Key Market Challenges & Risks of TCR-Based Antibody
Table 62. Key Industry Trends of TCR-Based Antibody
Table 63. TCR-Based Antibody Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. TCR-Based Antibody Distributors List
Table 66. TCR-Based Antibody Customer List
Table 67. Global TCR-Based Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global TCR-Based Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas TCR-Based Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas TCR-Based Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC TCR-Based Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC TCR-Based Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe TCR-Based Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe TCR-Based Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa TCR-Based Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa TCR-Based Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global TCR-Based Antibody Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global TCR-Based Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global TCR-Based Antibody Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global TCR-Based Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Adaptimmune Therapeutics Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 82. Adaptimmune Therapeutics TCR-Based Antibody Product Portfolios and Specifications
Table 83. Adaptimmune Therapeutics TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Adaptimmune Therapeutics Main Business
Table 85. Adaptimmune Therapeutics Latest Developments
Table 86. Celgene Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 87. Celgene TCR-Based Antibody Product Portfolios and Specifications
Table 88. Celgene TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Celgene Main Business
Table 90. Celgene Latest Developments
Table 91. Immunocore Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 92. Immunocore TCR-Based Antibody Product Portfolios and Specifications
Table 93. Immunocore TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Immunocore Main Business
Table 95. Immunocore Latest Developments
Table 96. Kuur Therapeutics Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 97. Kuur Therapeutics TCR-Based Antibody Product Portfolios and Specifications
Table 98. Kuur Therapeutics TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Kuur Therapeutics Main Business
Table 100. Kuur Therapeutics Latest Developments
Table 101. Lion TCR Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 102. Lion TCR TCR-Based Antibody Product Portfolios and Specifications
Table 103. Lion TCR TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Lion TCR Main Business
Table 105. Lion TCR Latest Developments
Table 106. Kite Pharma Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 107. Kite Pharma TCR-Based Antibody Product Portfolios and Specifications
Table 108. Kite Pharma TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Kite Pharma Main Business
Table 110. Kite Pharma Latest Developments
Table 111. Takara Bio Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 112. Takara Bio TCR-Based Antibody Product Portfolios and Specifications
Table 113. Takara Bio TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Takara Bio Main Business
Table 115. Takara Bio Latest Developments
Table 116. Ziopharm Oncology Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 117. Ziopharm Oncology TCR-Based Antibody Product Portfolios and Specifications
Table 118. Ziopharm Oncology TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Ziopharm Oncology Main Business
Table 120. Ziopharm Oncology Latest Developments
Table 121. GlaxoSmithKline Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 122. GlaxoSmithKline TCR-Based Antibody Product Portfolios and Specifications
Table 123. GlaxoSmithKline TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. GlaxoSmithKline Main Business
Table 125. GlaxoSmithKline Latest Developments
Table 126. Merck Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 127. Merck TCR-Based Antibody Product Portfolios and Specifications
Table 128. Merck TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Merck Main Business
Table 130. Merck Latest Developments
Table 131. Juno Theraprutics Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 132. Juno Theraprutics TCR-Based Antibody Product Portfolios and Specifications
Table 133. Juno Theraprutics TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Juno Theraprutics Main Business
Table 135. Juno Theraprutics Latest Developments
Table 1. TCR-Based Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. TCR-Based Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of NY-ESO-1
Table 4. Major Players of p53
Table 5. Major Players of WT-1
Table 6. Major Players of EBv
Table 7. Major Players of Others
Table 8. Global TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 9. Global TCR-Based Antibody Sales Market Share by Type (2018-2023)
Table 10. Global TCR-Based Antibody Revenue by Type (2018-2023) & ($ million)
Table 11. Global TCR-Based Antibody Revenue Market Share by Type (2018-2023)
Table 12. Global TCR-Based Antibody Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 14. Global TCR-Based Antibody Sales Market Share by Application (2018-2023)
Table 15. Global TCR-Based Antibody Revenue by Application (2018-2023)
Table 16. Global TCR-Based Antibody Revenue Market Share by Application (2018-2023)
Table 17. Global TCR-Based Antibody Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global TCR-Based Antibody Sales by Company (2018-2023) & (K Units)
Table 19. Global TCR-Based Antibody Sales Market Share by Company (2018-2023)
Table 20. Global TCR-Based Antibody Revenue by Company (2018-2023) ($ Millions)
Table 21. Global TCR-Based Antibody Revenue Market Share by Company (2018-2023)
Table 22. Global TCR-Based Antibody Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers TCR-Based Antibody Producing Area Distribution and Sales Area
Table 24. Players TCR-Based Antibody Products Offered
Table 25. TCR-Based Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global TCR-Based Antibody Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global TCR-Based Antibody Sales Market Share Geographic Region (2018-2023)
Table 30. Global TCR-Based Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global TCR-Based Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global TCR-Based Antibody Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global TCR-Based Antibody Sales Market Share by Country/Region (2018-2023)
Table 34. Global TCR-Based Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global TCR-Based Antibody Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas TCR-Based Antibody Sales by Country (2018-2023) & (K Units)
Table 37. Americas TCR-Based Antibody Sales Market Share by Country (2018-2023)
Table 38. Americas TCR-Based Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas TCR-Based Antibody Revenue Market Share by Country (2018-2023)
Table 40. Americas TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 41. Americas TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 42. APAC TCR-Based Antibody Sales by Region (2018-2023) & (K Units)
Table 43. APAC TCR-Based Antibody Sales Market Share by Region (2018-2023)
Table 44. APAC TCR-Based Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC TCR-Based Antibody Revenue Market Share by Region (2018-2023)
Table 46. APAC TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 47. APAC TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 48. Europe TCR-Based Antibody Sales by Country (2018-2023) & (K Units)
Table 49. Europe TCR-Based Antibody Sales Market Share by Country (2018-2023)
Table 50. Europe TCR-Based Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe TCR-Based Antibody Revenue Market Share by Country (2018-2023)
Table 52. Europe TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 53. Europe TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa TCR-Based Antibody Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa TCR-Based Antibody Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa TCR-Based Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa TCR-Based Antibody Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa TCR-Based Antibody Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa TCR-Based Antibody Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of TCR-Based Antibody
Table 61. Key Market Challenges & Risks of TCR-Based Antibody
Table 62. Key Industry Trends of TCR-Based Antibody
Table 63. TCR-Based Antibody Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. TCR-Based Antibody Distributors List
Table 66. TCR-Based Antibody Customer List
Table 67. Global TCR-Based Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global TCR-Based Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas TCR-Based Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas TCR-Based Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC TCR-Based Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC TCR-Based Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe TCR-Based Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe TCR-Based Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa TCR-Based Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa TCR-Based Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global TCR-Based Antibody Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global TCR-Based Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global TCR-Based Antibody Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global TCR-Based Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Adaptimmune Therapeutics Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 82. Adaptimmune Therapeutics TCR-Based Antibody Product Portfolios and Specifications
Table 83. Adaptimmune Therapeutics TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Adaptimmune Therapeutics Main Business
Table 85. Adaptimmune Therapeutics Latest Developments
Table 86. Celgene Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 87. Celgene TCR-Based Antibody Product Portfolios and Specifications
Table 88. Celgene TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Celgene Main Business
Table 90. Celgene Latest Developments
Table 91. Immunocore Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 92. Immunocore TCR-Based Antibody Product Portfolios and Specifications
Table 93. Immunocore TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Immunocore Main Business
Table 95. Immunocore Latest Developments
Table 96. Kuur Therapeutics Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 97. Kuur Therapeutics TCR-Based Antibody Product Portfolios and Specifications
Table 98. Kuur Therapeutics TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Kuur Therapeutics Main Business
Table 100. Kuur Therapeutics Latest Developments
Table 101. Lion TCR Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 102. Lion TCR TCR-Based Antibody Product Portfolios and Specifications
Table 103. Lion TCR TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Lion TCR Main Business
Table 105. Lion TCR Latest Developments
Table 106. Kite Pharma Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 107. Kite Pharma TCR-Based Antibody Product Portfolios and Specifications
Table 108. Kite Pharma TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Kite Pharma Main Business
Table 110. Kite Pharma Latest Developments
Table 111. Takara Bio Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 112. Takara Bio TCR-Based Antibody Product Portfolios and Specifications
Table 113. Takara Bio TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Takara Bio Main Business
Table 115. Takara Bio Latest Developments
Table 116. Ziopharm Oncology Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 117. Ziopharm Oncology TCR-Based Antibody Product Portfolios and Specifications
Table 118. Ziopharm Oncology TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Ziopharm Oncology Main Business
Table 120. Ziopharm Oncology Latest Developments
Table 121. GlaxoSmithKline Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 122. GlaxoSmithKline TCR-Based Antibody Product Portfolios and Specifications
Table 123. GlaxoSmithKline TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. GlaxoSmithKline Main Business
Table 125. GlaxoSmithKline Latest Developments
Table 126. Merck Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 127. Merck TCR-Based Antibody Product Portfolios and Specifications
Table 128. Merck TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Merck Main Business
Table 130. Merck Latest Developments
Table 131. Juno Theraprutics Basic Information, TCR-Based Antibody Manufacturing Base, Sales Area and Its Competitors
Table 132. Juno Theraprutics TCR-Based Antibody Product Portfolios and Specifications
Table 133. Juno Theraprutics TCR-Based Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Juno Theraprutics Main Business
Table 135. Juno Theraprutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of TCR-Based Antibody
Figure 2. TCR-Based Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TCR-Based Antibody Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global TCR-Based Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. TCR-Based Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of NY-ESO-1
Figure 10. Product Picture of p53
Figure 11. Product Picture of WT-1
Figure 12. Product Picture of EBv
Figure 13. Product Picture of Others
Figure 14. Global TCR-Based Antibody Sales Market Share by Type in 2022
Figure 15. Global TCR-Based Antibody Revenue Market Share by Type (2018-2023)
Figure 16. TCR-Based Antibody Consumed in Hospitals
Figure 17. Global TCR-Based Antibody Market: Hospitals (2018-2023) & (K Units)
Figure 18. TCR-Based Antibody Consumed in Specialized Clinics
Figure 19. Global TCR-Based Antibody Market: Specialized Clinics (2018-2023) & (K Units)
Figure 20. TCR-Based Antibody Consumed in Pharma and Biotech Research Laboratories.
Figure 21. Global TCR-Based Antibody Market: Pharma and Biotech Research Laboratories. (2018-2023) & (K Units)
Figure 22. TCR-Based Antibody Consumed in Gene Therapy Centers
Figure 23. Global TCR-Based Antibody Market: Gene Therapy Centers (2018-2023) & (K Units)
Figure 24. TCR-Based Antibody Consumed in Others
Figure 25. Global TCR-Based Antibody Market: Others (2018-2023) & (K Units)
Figure 26. Global TCR-Based Antibody Sales Market Share by Application (2022)
Figure 27. Global TCR-Based Antibody Revenue Market Share by Application in 2022
Figure 28. TCR-Based Antibody Sales Market by Company in 2022 (K Units)
Figure 29. Global TCR-Based Antibody Sales Market Share by Company in 2022
Figure 30. TCR-Based Antibody Revenue Market by Company in 2022 ($ Million)
Figure 31. Global TCR-Based Antibody Revenue Market Share by Company in 2022
Figure 32. Global TCR-Based Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global TCR-Based Antibody Revenue Market Share by Geographic Region in 2022
Figure 34. Americas TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 35. Americas TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 36. APAC TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 37. APAC TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 38. Europe TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 39. Europe TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 42. Americas TCR-Based Antibody Sales Market Share by Country in 2022
Figure 43. Americas TCR-Based Antibody Revenue Market Share by Country in 2022
Figure 44. Americas TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 45. Americas TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 46. United States TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC TCR-Based Antibody Sales Market Share by Region in 2022
Figure 51. APAC TCR-Based Antibody Revenue Market Share by Regions in 2022
Figure 52. APAC TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 53. APAC TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 54. China TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 58. India TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe TCR-Based Antibody Sales Market Share by Country in 2022
Figure 62. Europe TCR-Based Antibody Revenue Market Share by Country in 2022
Figure 63. Europe TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 64. Europe TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 65. Germany TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 66. France TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa TCR-Based Antibody Sales Market Share by Country in 2022
Figure 71. Middle East & Africa TCR-Based Antibody Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 74. Egypt TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of TCR-Based Antibody in 2022
Figure 80. Manufacturing Process Analysis of TCR-Based Antibody
Figure 81. Industry Chain Structure of TCR-Based Antibody
Figure 82. Channels of Distribution
Figure 83. Global TCR-Based Antibody Sales Market Forecast by Region (2024-2029)
Figure 84. Global TCR-Based Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global TCR-Based Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global TCR-Based Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global TCR-Based Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global TCR-Based Antibody Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of TCR-Based Antibody
Figure 2. TCR-Based Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TCR-Based Antibody Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global TCR-Based Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. TCR-Based Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of NY-ESO-1
Figure 10. Product Picture of p53
Figure 11. Product Picture of WT-1
Figure 12. Product Picture of EBv
Figure 13. Product Picture of Others
Figure 14. Global TCR-Based Antibody Sales Market Share by Type in 2022
Figure 15. Global TCR-Based Antibody Revenue Market Share by Type (2018-2023)
Figure 16. TCR-Based Antibody Consumed in Hospitals
Figure 17. Global TCR-Based Antibody Market: Hospitals (2018-2023) & (K Units)
Figure 18. TCR-Based Antibody Consumed in Specialized Clinics
Figure 19. Global TCR-Based Antibody Market: Specialized Clinics (2018-2023) & (K Units)
Figure 20. TCR-Based Antibody Consumed in Pharma and Biotech Research Laboratories.
Figure 21. Global TCR-Based Antibody Market: Pharma and Biotech Research Laboratories. (2018-2023) & (K Units)
Figure 22. TCR-Based Antibody Consumed in Gene Therapy Centers
Figure 23. Global TCR-Based Antibody Market: Gene Therapy Centers (2018-2023) & (K Units)
Figure 24. TCR-Based Antibody Consumed in Others
Figure 25. Global TCR-Based Antibody Market: Others (2018-2023) & (K Units)
Figure 26. Global TCR-Based Antibody Sales Market Share by Application (2022)
Figure 27. Global TCR-Based Antibody Revenue Market Share by Application in 2022
Figure 28. TCR-Based Antibody Sales Market by Company in 2022 (K Units)
Figure 29. Global TCR-Based Antibody Sales Market Share by Company in 2022
Figure 30. TCR-Based Antibody Revenue Market by Company in 2022 ($ Million)
Figure 31. Global TCR-Based Antibody Revenue Market Share by Company in 2022
Figure 32. Global TCR-Based Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global TCR-Based Antibody Revenue Market Share by Geographic Region in 2022
Figure 34. Americas TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 35. Americas TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 36. APAC TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 37. APAC TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 38. Europe TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 39. Europe TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa TCR-Based Antibody Sales 2018-2023 (K Units)
Figure 41. Middle East & Africa TCR-Based Antibody Revenue 2018-2023 ($ Millions)
Figure 42. Americas TCR-Based Antibody Sales Market Share by Country in 2022
Figure 43. Americas TCR-Based Antibody Revenue Market Share by Country in 2022
Figure 44. Americas TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 45. Americas TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 46. United States TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC TCR-Based Antibody Sales Market Share by Region in 2022
Figure 51. APAC TCR-Based Antibody Revenue Market Share by Regions in 2022
Figure 52. APAC TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 53. APAC TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 54. China TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 58. India TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe TCR-Based Antibody Sales Market Share by Country in 2022
Figure 62. Europe TCR-Based Antibody Revenue Market Share by Country in 2022
Figure 63. Europe TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 64. Europe TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 65. Germany TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 66. France TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa TCR-Based Antibody Sales Market Share by Country in 2022
Figure 71. Middle East & Africa TCR-Based Antibody Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa TCR-Based Antibody Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa TCR-Based Antibody Sales Market Share by Application (2018-2023)
Figure 74. Egypt TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country TCR-Based Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of TCR-Based Antibody in 2022
Figure 80. Manufacturing Process Analysis of TCR-Based Antibody
Figure 81. Industry Chain Structure of TCR-Based Antibody
Figure 82. Channels of Distribution
Figure 83. Global TCR-Based Antibody Sales Market Forecast by Region (2024-2029)
Figure 84. Global TCR-Based Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global TCR-Based Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global TCR-Based Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global TCR-Based Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global TCR-Based Antibody Revenue Market Share Forecast by Application (2024-2029)
